2026 NPPES data Ophthalmology Physician NPI 1407865538 MD
Verify on CMS →

ROBERT CYKIERT, MD

Ophthalmology Physician in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 386 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
45%
generic claims · 55% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
19.1819/100
▼ 64 pts below national avg 83.1 · [object Object]
Industry payments
$18.5K
33 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: ROBERT CYKIERT, MD is a Ophthalmology Physician ([object Object]) practicing in NEW YORK, New York with a Medicare Part D prescribing footprint of 2K claims across 386 beneficiaries — 55% brand-name prescribing . Their CMS MIPS Final Score of 19.1819/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $18.5K across 33 transactions are disclosed under CMS Open Payments (Sunshine Act).

What the federal data shows

ROBERT CYKIERT, MD reported a CMS MIPS final score of 19.1819/100 — below the 83.1 national average — and filed 1,866 Medicare Part D claims in 2023.

19.1819/100
MIPS score · -64 vs avg
2K
Part D claims, 2023
45%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ROBERT CYKIERT, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

19 2nd percentile higher than 2% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). This entry sits in this band. 20–30: 3,069 scored providers (1%). Above this entry. 30–40: 2,746 scored providers (1%). Above this entry. 40–50: 2,928 scored providers (1%). Above this entry. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

ROBERT CYKIERT, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

ROBERT CYKIERT, MD at a glance

Below national average

NPI registry status

Active

Issued 08/07/2006

NPI 1407865538

Primary specialty

Ophthalmology Physician

Mid-sized

22,090 US NPIs in this specialty

Medicare Part D claims

1,866 31% vs specialty avg

2023 prescription claims

Specialty avg: 1,420

MIPS final score

19.1819/100 63.918099999999995% pts

Below average band

vs 83.1 national avg

Specialty distribution in New York

How Ophthalmology Physician compares to other specialties among New York providers

New York providers

Ophthalmology Physician share within New York

1. Ophthalmology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ophthalmology Physician share within New York

Medicare quality performance — MIPS

ROBERT CYKIERT, MD's 2023 MIPS final score plotted against the Ophthalmology Physician national average

Below national average
MIPS Final Score
19.1819/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Ophthalmology Physician) — 19.1819/100 vs national avg 83.1

0%100%National avg83%19.2%
MIPS final score (Ophthalmology Physician) — 19.1819/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ROBERT CYKIERT, MD is a Ophthalmology Physician provider practicing in NEW YORK, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1407865538. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ROBERT CYKIERT, MD appears in the CMS NPPES registry as a Ophthalmology Physician provider holding MD credentials at 345 E 37TH ST RM 210, NEW YORK, NY, 10016, with a listed phone of (212) 922-1430. NPI 1407865538 was issued on 08/07/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CYKIERT most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,866 prescription claims written by this provider, covering 386 Medicare beneficiaries and totaling roughly $572K in drug spend, split 55% brand-name and 45% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 19.1819/100 for the 2023 performance year (Quality 0, Cost 63.9396), compared with the national average of 83.1.

Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

345 E 37TH ST RM 210
NEW YORK, NY 10016

Provider Details

NPI 1407865538
Specialty Ophthalmology Physician
Credentials MD
Gender Male
NPI Issued 08/07/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

19.1819
Final Score
Avg: 83.1
0
Quality
63.9396
Cost

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ROBERT CYKIERT, MD. Source: openpaymentsdata.cms.gov.

Total received

$18.5K

Largest payer

SUN PHARMACEUTICAL INDUSTRIES INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to ROBERT CYKIERT, MD. To verify ROBERT CYKIERT, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

ROBERT CYKIERT, MD — brand share 55.0%
Specialty average (est.)

55% brand-name claims vs 45% generic, on 1,866 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,866
Total Claims
$572K
Total Drug Cost
386
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
3,753
Total Day Supply
108,892
Brand vs Generic
55% brand / 45% generic
Brand Drug Cost
$500K
Generic Drug Cost
$71K

Patient Demographics

Average Patient Age
78.5 years
Avg HCC Risk Score
1.05
Gender Split
55% female / 45% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
288
Prednisolone Acetate
170
Timolol Maleate
121
Lumigan
Bimatoprost
112
Simbrinza
Brinzolamide/Brimonidine Tart
111
Restasis
Cyclosporine
99
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
86
Dorzolamide Hcl
76
Brimonidine Tartrate
75
Rhopressa
Netarsudil Mesylate
64

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmology Physician Overview

How ROBERT CYKIERT, MD fits within the Ophthalmology Physician landscape nationally.

22,090
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider

ROBERT CYKIERT, MD's 1,866 claims are above the specialty average of 1,420.

Nearby Ophthalmology Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as CYKIERT.

Compare Ophthalmology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ROBERT CYKIERT, MD's specialty?
ROBERT CYKIERT, MD specializes in Ophthalmology Physician and practices in NEW YORK, New York. Credentials: MD.
How much does ROBERT CYKIERT, MD prescribe under Medicare Part D?
In 2023, ROBERT CYKIERT, MD wrote 1,866 Medicare Part D claims totaling $572K in drug costs for 386 beneficiaries.
What is ROBERT CYKIERT, MD's Medicare quality score?
ROBERT CYKIERT, MD has a CMS MIPS Final Score of 19.1819/100 (Quality: 0, Cost: 63.9396). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ROBERT CYKIERT, MD located?
ROBERT CYKIERT, MD is located at 345 E 37TH ST RM 210, NEW YORK, NY, 10016. Phone: (212) 922-1430.
What is ROBERT CYKIERT, MD's NPI number?
ROBERT CYKIERT, MD's National Provider Identifier (NPI) is 1407865538, issued on 08/07/2006.
Does ROBERT CYKIERT, MD prescribe more brand-name or generic drugs?
ROBERT CYKIERT, MD's prescribing is 55% brand-name and 45% generic drugs by claim count, with $500K in brand drug costs.
How many Ophthalmology Physician providers are there in the US?
There are 22,090 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does ROBERT CYKIERT, MD prescribe most often?
Based on 2023 Medicare Part D data, ROBERT CYKIERT, MD's most frequently prescribed drugs include Latanoprost, Prednisolone Acetate, Timolol Maleate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ROBERT CYKIERT, MD accept Medicare?
ROBERT CYKIERT, MD appears in CMS Medicare data with 1,866 Part D claims and 386 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ROBERT CYKIERT, MD's credentials?
ROBERT CYKIERT, MD's NPI is 1407865538 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology